Dr. Jagdish S Hiremath
DM(Card), DNB(Card), FACC
Eminent speaker with more than 34 years of experience & Director Cath lab, Rubu Hall Clinic, Pune
Related Webinars
ICOSIFY Symposia Series -...
12 Dec
HF Peer Exchange Forum
03 Dec
HF Peer Exchange Forum
01 Oct
Strike Early Strike Hard
29 Sep
Close
Topics Covered
KOL's discuss about Icosapent ethyl & share scientific data & interesting case studies & the role played by Icosapent ethyl in addressing the unmet need in Cardiovascular therapy
Meet the Speakers
Related Videos
-
4:46CardiacBookmark this
How Long Would It Take for Patients to Respond to Lipid Lowering Therapy in High Risk Patients or Polyvascular Disease? by Dr. M. Srinivasa Rao
buttonBookmark this
-
6:54CardiacBookmark this
What is the Importance of Aggressive Lipid Lowering in Acute Phase Post ACS in High Risk Patient? by Dr. M Srinivasa Rao
buttonBookmark this
-
3:18CardiacBookmark this
Why is it Important to lower LDL in Complex ACS Patient With multiple Risk Factors? by Dr. Jamshed J dalal
buttonBookmark this
-
1:38buttonBookmark this
-
10:55buttonBookmark this
-
13:35buttonBookmark this
-
11:11buttonBookmark this
-
13:21buttonBookmark this
-
39:09buttonBookmark this
-
1:14:29buttonBookmark this
Related Videos
-
2:22buttonBookmark this